Abiopharma

StepStone Group and PitchBook Announce Partnership to Deliver Deal-Level Performance & Operating Metrics to Private Market Participants

Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

EPAM Systems, Inc. - EPAM & Anthropic Team Up to Build the Future of Enterprise Transformation with Safe, Applied AI

Nuvation Bio Inc. - Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI®(taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer

Halozyme - Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™Technology

Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

Liberty Global Tech Ventures Announces Investment in AI Security Firm, XBOW